Therapeutic potential and strategies for inhibiting tumor necrosis factor-α

被引：178

作者：

Newton, RC

Decicco, CP

机构：

[1] Dupont Merck Pharmaceut Co, Expt Stn, Dept Inflammatory Dis Res, Wilmington, DE 19880 USA

[2] Dupont Merck Pharmaceut Co, Expt Stn, Dept Chem & Phys Sci, Wilmington, DE 19880 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1999年 / 42卷 / 13期

关键词：

D O I：

10.1021/jm980541n

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：2295 / 2314

页数：20

共 248 条

[1]

ABRAHAM E, 1994, CLIN EXP IMMUNOL, V98, P29

[2]

Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93

[3] Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H [J].

Alicea, C ;

Belkowski, S ;

Eisenstein, TK ;

Adler, MW ;

Rogers, TJ .

JOURNAL OF NEUROIMMUNOLOGY, 1996, 64 (01) :83-90

[4] G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS [J].

ALTAVILLA, D ;

SQUADRITO, F ;

CANALE, P ;

IOCULANO, M ;

SQUADRITO, G ;

CAMPO, GM ;

SERRANO, M ;

SARDELLA, A ;

URNA, G ;

SPIGNOLI, G ;

CAPUTI, AP .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 286 (01) :31-39

[5]

Aoudjit F, 1997, CELL GROWTH DIFFER, V8, P335

[6] IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].

AUPHAN, N ;

DIDONATO, JA ;

ROSETTE, C ;

HELMBERG, A ;

KARIN, M .

SCIENCE, 1995, 270 (5234) :286-290

[7] NF-kappa B: Ten years after [J].

Baeuerle, PA ;

Baltimore, D .

CELL, 1996, 87 (01) :13-20

[8] CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION [J].

BANNER, DW ;

DARCY, A ;

JANES, W ;

GENTZ, R ;

SCHOENFELD, HJ ;

BROGER, C ;

LOETSCHER, H ;

LESSLAUER, W .

CELL, 1993, 73 (03) :431-445

[9]

Bazzoni F, 1995, J INFLAMM, V45, P221

[10]

BEAVO JA, 1994, MOL PHARMACOL, V46, P399

← 1 2 3 4 5 6 7 8 9 10 →